The European Union has approved a new HIV treatment that combines the use of Vocabria (cabotegravir injection and tablets) and Janssen Pharmaceutical’s Rekambys (rilpivirine injection and Eudurant (rilpivirine tablets).
Both ViiV Healthcare and The Janssen Pharmaceutical Companies of Johnson & Johnson made…
